Table 1 Patients baseline characteristics.

From: Real-world comparison of neoadjuvant chemoimmunotherapy and chemotherapy in muscle-invasive bladder cancer

 

NAC(n = 71)

NAC.NICB (n = 29)

P value

Age (years)†

62.56 ± 10.56

65.41 ± 8.97

0.205a

Sex

  

0.793b

Male

56(78.9%)

22(75.9%)

 

Female

15(21.1%)

7(24.1%)

 

Smoking history

  

0.827b

Smoker

30(42.3%)

13(44.8%)

 

Nonsmoker

41(57.7%)

16(55.2%)

 

T stage

  

0.334c

T2

46(64.8%)

14(48.3%)

 

T3

20(28.2%)

12(41.4%)

 

T4

5(7.0%)

3(10.3%)

 

N stage

  

0.024*c

N0

58(81.7%)

17(58.6%)

 

N1

9(12.7%)

8(27.6%)

 

N2

4(5.6%)

2(6.9%)

 

N3

0(0.0%)

2(6.9%)

 

Grade

  

>0.999c

Low grade

2(2.8%)

1(3.4%)

 

High grade

69(97.2%)

28(96.6%)

 

Histology

  

0.378b

Pure UC

38(53.5%)

12(41.4%)

 

VH-UC

33(46.5%)

17(58.6%)

 
  1. UC: urothelial carcinoma; VH: variation histological.
  2. †Data are presented as mean ± SD.
  3. aTwo-sample t-tests.
  4. bChi-square test.
  5. cFisher’s exact test.
  6. * P < 0.05 was recognized as statistically different.
Back to article page